MN Saleh

682 citations
25 papers · 557 indexed · h-index 13
Topics
Radiopharmaceutical Chemistry and Applications (6 papers)Colorectal Cancer Treatments and Studies (6 papers)HER2/EGFR in Cancer Research (6 papers)

In The Last Decade

MN Saleh

25 papers receiving 530 citations

Peers

MN Saleh
Comparison fields: 5 of 67
  • Immunology 243
  • Oncology 229
  • Radiology, Nuclear Medicine and Imaging 215
  • Molecular Biology 138
  • Hematology 101
Replace Sigrid Klein with:
Sigrid Klein Germany
Jean E. Surfus United States
Matthias Kreuzaler Switzerland
Jonathan Treisman United States
Christophe de Romeuf France
Patrick F. Joyce United States
Siao‐Yi Wang United States
Xing-Zhong Xia United States
Meryn Griffiths United Kingdom
J Klarnet United States
MN Saleh relative to Sigrid Klein Germany Sigrid Klein's profile →
Citations per field
00.5×1.5×
Sigrid Klein · 1×
Citations per year

Countries citing papers authored by MN Saleh

Since Specialization
Citations

This map shows the geographic impact of MN Saleh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MN Saleh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MN Saleh more than expected).

Fields of papers citing papers by MN Saleh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MN Saleh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MN Saleh. The network helps show where MN Saleh may publish in the future.

Co-authorship network of co-authors of MN Saleh

This figure shows the co-authorship network connecting the top 25 collaborators of MN Saleh. A scholar is included among the top collaborators of MN Saleh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MN Saleh. MN Saleh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 6
3 12
4 5
5 14
6 25
7 14
8 5
9 3
10 4
11
Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancer.
8
12 124
13
A phase I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancer.
17
14 20
15 19
16 14
17 99
18 72
19 2
20 34

About MN Saleh

MN Saleh is a scholar working on Hematology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 25 papers that have together received 557 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (6 papers), Colorectal Cancer Treatments and Studies (6 papers) and HER2/EGFR in Cancer Research (6 papers). The work is most often cited by research in Immunology (243 citations), Radiology, Nuclear Medicine and Imaging (215 citations) and Hematology (101 citations). MN Saleh has collaborated with scholars based in United States, Canada and Greece. Frequent co-authors include AF LoBuglio, M.B. Khazaeli, Richard Wheeler, Richard A. Carrano, Howard T. Holden, William J. Huster, Albert F. LoBuglio, David H. Munn, L M Weiner and SJ Goldman. Their work appears in journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026